Compare Goodyear Tire & Rubber Co (GT) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Tire & Rubber Co vs Invesco Ltd. — how do they compare? Goodyear Tire & Rubber Co trades at $4.69 (market cap $1.37B), while Invesco Ltd. trades at $29.52 (market cap $13.28B). The key difference: Invesco Ltd. is far larger — about 9.7× Goodyear Tire & Rubber Co's market cap, and Invesco Ltd. pays a 2.86% dividend while Goodyear Tire & Rubber Co pays none. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and Invesco Ltd. for 77 Days on average.
| GT | IVZ | |
|---|---|---|
Market Cap | $1.37B | $13.28B |
Volume | 9,470,773 | 3,698,033 |
Sector | Consumer Cyclical | Financials |
52-Week High | $10.54 | $33.31 |
52-Week Low | $4.66 | $22.44 |
Typical Hold Time | 57 Days | 77 Days |
Enterprise Value | $8.72B | $23.45B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Goodyear Tire & Rubber (GT) trades at $4.68, down 0.21% on the day, reflecting persistent bearish technicals and weak profitability. The stock shows deeply discounted valuation ratios with a P/E of 4.69 and P/B of 0.48, but fundamentals are challenged by a net loss of $1.72 billion in 2025 and negative margins. Recent news highlights the company's ongoing turnaround efforts, including restructuring and a focus on premium tire segments, amid significant cash flow volatility and high debt levels.
The outlook remains cautious with a consensus analyst price target of $8.00 suggesting potential upside, but execution risks on margin improvement and debt management are critical. Investment opportunity hinges on successful restructuring, while risks include competitive pressures, volume declines, and macroeconomic headwinds impacting the auto sector.
Invesco (IVZ) trades at $29.51, down 3.25% today, with bearish technical signals dominating. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Despite negative net income margins in 2025, operating cash flow remains strong at $1.53 billion, and analyst consensus leans toward Hold with a $33.71 price target. Recent news highlights ETF expansions and AUM growth to $2.56 trillion in August 2026.
The outlook is cautious; IVZ faces profitability challenges with negative ROE and net margins, but solid cash flow and analyst buy ratings (42.86%) suggest recovery potential. Risks include earnings volatility and competitive ETF pressures, while institutional sentiment is neutral. The stock's current price near the low end of analyst targets ($28-$41) may appeal to value investors betting on operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
